financetom
Business
financetom
/
Business
/
EU regulator recommends approval for ARS pharma's nasal spray alternative to EpiPen
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU regulator recommends approval for ARS pharma's nasal spray alternative to EpiPen
Jun 28, 2024 4:17 AM

June 28 (Reuters) - ARS Pharmaceuticals ( SPRY ) said on

Friday the European Medicines Agency (EMA) recommended the

approval of its needle-free emergency treatment for allergic

reactions.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved